These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
432 related articles for article (PubMed ID: 18570896)
1. Biostructure of fecal microbiota in healthy subjects and patients with chronic idiopathic diarrhea. Swidsinski A; Loening-Baucke V; Verstraelen H; Osowska S; Doerffel Y Gastroenterology; 2008 Aug; 135(2):568-79. PubMed ID: 18570896 [TBL] [Abstract][Full Text] [Related]
2. [Functional biostructure of colonic microbiota (central fermenting area, germinal stock area and separating mucus layer) in healthy subjects and patients with diarrhea treated with Saccharomyces boulardii]. Swidsinski A; Loening-Baucke V; Kirsch S; Doerffel Y Gastroenterol Clin Biol; 2010 Sep; 34 Suppl 1():S79-92. PubMed ID: 20889010 [TBL] [Abstract][Full Text] [Related]
3. Molecular analysis of the digestive microbiota in a gnotobiotic mouse model during antibiotic treatment: Influence of Saccharomyces boulardii. Barc MC; Charrin-Sarnel C; Rochet V; Bourlioux F; Sandré C; Boureau H; Doré J; Collignon A Anaerobe; 2008 Oct; 14(4):229-33. PubMed ID: 18511310 [TBL] [Abstract][Full Text] [Related]
4. Modulation of the fecal microbiota by the intake of a Lactobacillus johnsonii La1-containing product in human volunteers. Garrido D; Suau A; Pochart P; Cruchet S; Gotteland M FEMS Microbiol Lett; 2005 Jul; 248(2):249-56. PubMed ID: 15970400 [TBL] [Abstract][Full Text] [Related]
5. Common biostructure of the colonic microbiota in neuroendocrine tumors and Crohn's disease and the effect of therapy. Dörffel Y; Swidsinski A; Loening-Baucke V; Wiedenmann B; Pavel M Inflamm Bowel Dis; 2012 Sep; 18(9):1663-71. PubMed ID: 22113988 [TBL] [Abstract][Full Text] [Related]
7. Differences between the fecal microbiota of coeliac infants and healthy controls. Collado MC; Calabuig M; Sanz Y Curr Issues Intest Microbiol; 2007 Mar; 8(1):9-14. PubMed ID: 17489434 [TBL] [Abstract][Full Text] [Related]
8. Increase in fecal primary bile acids and dysbiosis in patients with diarrhea-predominant irritable bowel syndrome. Duboc H; Rainteau D; Rajca S; Humbert L; Farabos D; Maubert M; Grondin V; Jouet P; Bouhassira D; Seksik P; Sokol H; Coffin B; Sabaté JM Neurogastroenterol Motil; 2012 Jun; 24(6):513-20, e246-7. PubMed ID: 22356587 [TBL] [Abstract][Full Text] [Related]
9. Molecular studies of fecal anaerobic commensal bacteria in acute diarrhea in children. Balamurugan R; Janardhan HP; George S; Raghava MV; Muliyil J; Ramakrishna BS J Pediatr Gastroenterol Nutr; 2008 May; 46(5):514-9. PubMed ID: 18493205 [TBL] [Abstract][Full Text] [Related]
10. Effects of yogurt and bifidobacteria supplementation on the colonic microbiota in lactose-intolerant subjects. He T; Priebe MG; Zhong Y; Huang C; Harmsen HJ; Raangs GC; Antoine JM; Welling GW; Vonk RJ J Appl Microbiol; 2008 Feb; 104(2):595-604. PubMed ID: 17927751 [TBL] [Abstract][Full Text] [Related]
11. Molecular monitoring of the fecal microbiota of healthy human subjects during administration of lactulose and Saccharomyces boulardii. Vanhoutte T; De Preter V; De Brandt E; Verbeke K; Swings J; Huys G Appl Environ Microbiol; 2006 Sep; 72(9):5990-7. PubMed ID: 16957220 [TBL] [Abstract][Full Text] [Related]
12. Prospective randomized controlled study on the effects of Saccharomyces boulardii CNCM I-745 and amoxicillin-clavulanate or the combination on the gut microbiota of healthy volunteers. Kabbani TA; Pallav K; Dowd SE; Villafuerte-Galvez J; Vanga RR; Castillo NE; Hansen J; Dennis M; Leffler DA; Kelly CP Gut Microbes; 2017 Jan; 8(1):17-32. PubMed ID: 27973989 [TBL] [Abstract][Full Text] [Related]
13. Validation of fluorescent in situ hybridization combined with flow cytometry for assessing interindividual variation in the composition of human fecal microflora during long-term storage of samples. Rochet V; Rigottier-Gois L; Rabot S; Doré J J Microbiol Methods; 2004 Nov; 59(2):263-70. PubMed ID: 15369862 [TBL] [Abstract][Full Text] [Related]
15. Prophylactic Saccharomyces boulardii in the prevention of antibiotic-associated diarrhea: a prospective study. Can M; Beşirbellioglu BA; Avci IY; Beker CM; Pahsa A Med Sci Monit; 2006 Apr; 12(4):PI19-22. PubMed ID: 16572062 [TBL] [Abstract][Full Text] [Related]
17. Effect of lactulose and Saccharomyces boulardii administration on the colonic urea-nitrogen metabolism and the bifidobacteria concentration in healthy human subjects. De Preter V; Vanhoutte T; Huys G; Swings J; Rutgeerts P; Verbeke K Aliment Pharmacol Ther; 2006 Apr; 23(7):963-74. PubMed ID: 16573799 [TBL] [Abstract][Full Text] [Related]
18. Treatment of acute diarrhea with Saccharomyces boulardii in infants. Corrêa NB; Penna FJ; Lima FM; Nicoli JR; Filho LA J Pediatr Gastroenterol Nutr; 2011 Nov; 53(5):497-501. PubMed ID: 21734600 [TBL] [Abstract][Full Text] [Related]
19. [Effect of probiotic Saccharomyces boulardii on prevention of antibiotic-associated diarrhea in adult outpatients with amoxicillin treatment]. Bravo MV; Bunout D; Leiva L; de la Maza MP; Barrera G; de la Maza J; Hirsch S Rev Med Chil; 2008 Aug; 136(8):981-8. PubMed ID: 18949181 [TBL] [Abstract][Full Text] [Related]
20. Horizontal distribution of the fecal microbiota in adolescents with inflammatory bowel disease. Gosiewski T; Strus M; Fyderek K; Kowalska-Duplaga K; Wedrychowicz A; Jedynak-Wasowicz U; Sladek M; Pieczarkowski S; Adamski P; Heczko PB J Pediatr Gastroenterol Nutr; 2012 Jan; 54(1):20-7. PubMed ID: 21788912 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]